Written and maintained by CASRAI Editorial Board
Last updated
In the United Kingdom, any scientific procedure carried out on a living animal that is capable of causing pain, suffering, distress, or lasting harm is regulated under the Animals (Scientific Procedures) Act 1986 (ASPA). ASPA is the primary legislation governing animal research in Great Britain, enforced by the Home Office through a dedicated regulator, and it works through a three-licence system rather than a single blanket authorisation: an establishment has to be licensed to hold and use animals at all, a project has to be licensed separately before any programme of work can start, and every individual who actually carries out a regulated procedure needs their own personal authorisation. This guide covers how those three licences fit together, who regulates them, how local ethical review works underneath the legal minimum, and the public transparency requirement that makes UK animal research licensing unusually open by international standards.
What ASPA 1986 actually regulates
ASPA defines a “regulated procedure” as any scientific procedure applied to a “protected animal” that may cause that animal pain, suffering, distress, or lasting harm equivalent to, or higher than, that caused by inserting a hypodermic needle. A protected animal is any living vertebrate other than man, plus (since amendments transposing EU Directive 2010/63/EU took effect on 1 January 2013) one invertebrate species group: cephalopods such as octopus and squid, added in recognition of their capacity for pain and suffering. That 2013 amendment also brought UK law into close alignment with the EU Directive’s licensing structure and introduced two features this guide covers in detail below: a statutory local review body at every establishment, and a public non-technical summary for every authorised project.
Underpinning the whole system is the internationally recognised 3Rs framework — Replacement, Reduction, and Refinement, originated by William Russell and Rex Burch in 1959 — which ASPA and its associated guidance require applicants to demonstrably apply at every stage: replacing animal use with non-animal methods wherever scientifically possible, reducing the number of animals used to the minimum consistent with valid results, and refining procedures to minimise pain, suffering, and distress for animals that are still used. A harm-benefit analysis, weighing the likely harm to animals against the scientific or medical benefit the work is expected to produce, sits at the centre of every project licence decision.
The three licence types
ASPA licensing is deliberately layered: an establishment licence authorises a place, a project licence authorises a specific programme of work at that place, and a personal licence authorises an individual to carry out specific procedures. All three normally have to be in place, together, before any regulated procedure can lawfully happen.
Establishment licence (PEL)
A Place of business or scientific procedure Establishment Licence (PEL) authorises a specific site to hold and use protected animals for scientific procedures. The PEL holder is responsible for ensuring the establishment meets ASPA’s establishment licence standard conditions on a continuing basis — not just at the point of application — including maintaining adequate animal housing and care, appointing named individuals to statutory roles (such as a Named Animal Care and Welfare Officer, NACWO, and a Named Veterinary Surgeon, NVS), keeping records for regulatory inspection, and holding a business continuity plan for the animals in its care. Without a valid PEL, no project or personal licence at that site can be exercised.
Project licence (PPL)
A Project Licence (PPL) authorises a defined programme of research or testing — not an individual, and not a site in general, but a specific piece of work with a specific scientific objective. Before a PPL is granted, the regulator conducts a harm-benefit analysis against the 3Rs and the scientific justification submitted, and every authorised project is assigned a severity limit (non-recovery, mild, moderate, or severe) capping how much suffering any procedure in that project may cause. The PPL holder is accountable for the project staying within its authorised protocols and severity limits for its full duration, and for reporting departures from either.
Personal licence (PIL)
A Personal Licence (PIL) authorises a named individual to carry out specific regulated procedures on specific species, under a specific project licence. A PIL is tied to demonstrated competence in the procedures it covers (training and supervised sign-off, not just a paper qualification) and does not, on its own, authorise anything — a personal licence holder can only act within an establishment that holds a PEL and under a project that holds a PPL covering the same work.
ASRU: the Home Office regulator
The Animals in Science Regulation Unit (ASRU), part of the Home Office, is the body that actually issues and enforces all three licence types. Applications for all licence types are submitted through ASRU’s online licensing system, ASPeL. Beyond issuing licences, ASRU conducts compliance audits against standardised assessment criteria, reviews annual returns that establishments and project licence holders must submit documenting the procedures actually performed, and requires self-reporting of non-compliance — including a strict 72-hour notification requirement for any breach of an authorised severity limit. ASRU is also the body a licence holder must contact if a breach of the establishment licence’s Standard Condition 18 (which sets out general compliance and reporting obligations) occurs.
This centralises UK animal research regulation in a single national authority in a way that has no exact US parallel — in the United States, equivalent oversight is split between the USDA (Animal Welfare Act enforcement) and NIH’s Office of Laboratory Animal Welfare (PHS Policy compliance for federally funded work), with no single body issuing individual researcher-level licences the way ASRU issues personal licences. See the comparison section below.
AWERB: local ethical review underneath the licence
A licence from ASRU is the legal minimum, not the whole of an establishment’s oversight. Since the 2013 amendments, every PEL-holding establishment has been required to maintain an Animal Welfare and Ethical Review Body (AWERB) — a local committee that provides ongoing ethical and welfare scrutiny that sits alongside, and feeds into, the statutory licensing process rather than duplicating it.
AWERB’s core functions typically include: advising the PEL holder on animal welfare and ethical issues arising from the establishment’s work; providing local review and support for project licence applications before they go to ASRU, including advice on the practical application of the 3Rs to a specific proposed project; promoting the 3Rs and awareness of new techniques or refinements across the establishment; monitoring the welfare of animals from acquisition through to their end use, including retrospective review of projects with severe procedures; and advising on the care, retirement, and rehoming of animals no longer required for a project. Membership normally includes, at minimum, the Named Veterinary Surgeon, the Named Animal Care and Welfare Officer, someone with day-to-day responsibility for the animals, and at least one lay member independent of the establishment — a structural safeguard against the review body being entirely composed of people with a direct stake in the work being approved.
Non-technical summaries: the public transparency requirement
Once ASRU authorises a project licence, the Home Office publishes a non-technical summary (NTS) of that project. The NTS is written in plain, non-specialist language and is a public document — not an internal record — covering the project’s objectives, the anticipated harms and benefits, the species and approximate numbers of animals to be used, and how the 3Rs have been applied in the project’s design. Publishing an NTS for every authorised project is a statutory requirement, not a voluntary transparency initiative, and it makes the UK’s project-level disclosure meaningfully more granular than most comparable national systems, which more commonly publish only aggregate annual statistics rather than a public summary of each individual authorised project.
How this compares to the US IACUC/OLAW framework
Institutions researching this topic from a US context will recognise the underlying shape even though the legal mechanics differ. CASRAI’s existing coverage of IACUC and animal research oversight in the United States maps roughly onto ASPA as follows:
- An establishment’s Institutional Animal Care and Use Committee (IACUC) is the closest US analogue to AWERB — both are local, establishment-level bodies that review and approve proposed animal work and monitor it afterward — but IACUC approval is itself the primary authorisation event in the US system, whereas AWERB’s role is advisory local review feeding into a separate national licensing decision made by ASRU.
- ASRU’s national licensing function has no single US equivalent: it combines elements of USDA/Animal Welfare Act enforcement and NIH OLAW/PHS Policy oversight into one Home Office unit, and additionally issues individual researcher-level personal licences, which neither USDA nor OLAW does.
- Both systems are built on the same 3Rs framework, and both require a harm-benefit or cost-benefit style analysis before authorising work, but the UK’s public non-technical summary requirement for every authorised project has no US equivalent — US annual reporting (the USDA Form 7023 and NIH/OLAW Assurance reporting) is institution-level and largely aggregate, not a plain-language public summary of each individual approved project.
For a UK institution’s own internal committee structure, the Guide for the Care and Use of Laboratory Animals is a US/AAALAC-oriented reference and not a substitute for ASPA compliance, but its housing, husbandry, and veterinary-care content is broadly consistent with what UK establishment licence standard conditions and AWERB oversight expect in practice.
Frequently asked questions
Do I need all three ASPA licences, or just one?
Normally all three, together, for any given piece of regulated work: the establishment licence (PEL) for the site, the project licence (PPL) for the specific programme, and a personal licence (PIL) for each individual actually carrying out procedures. None of the three substitutes for the others.
What is the difference between a project licence and a personal licence?
A project licence authorises a defined programme of work and is held by the person scientifically responsible for that programme; it sets the species, procedures, and severity limits allowed. A personal licence authorises a named individual to carry out specific procedures, and only within the scope of a project licence that covers that work — it does not authorise anything on its own.
What does ASRU actually do?
ASRU, the Home Office’s Animals in Science Regulation Unit, issues and enforces all three ASPA licence types, reviews project licence applications via a harm-benefit analysis, runs compliance audits against establishments, and receives mandatory self-reported non-compliance, including severity-limit breaches within 72 hours.
Is AWERB a legal requirement or just best practice?
It is a statutory requirement: every establishment holding a PEL has had to maintain an AWERB since the 2013 amendments to ASPA that transposed EU Directive 2010/63/EU. It is not optional local policy.
Who has to publish a non-technical summary, and where?
The Home Office publishes a non-technical summary for every project licence it authorises, as part of granting the PPL — it is a statutory publication requirement attached to the licence, not something the applicant separately chooses to make public.
Does ASPA 1986 still apply after the UK left the EU?
Yes. ASPA is UK domestic legislation; the 2013 amendments that added AWERB, non-technical summaries, and cephalopod coverage transposed an EU directive into UK law, but they did so by amending ASPA itself, so those provisions remain in force as UK law independent of EU membership.
